# Sprim Ventures

Sprim Ventures is a Venture Capital based in Singapore, Singapore.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore
- **Founded:** 2005
- **Assets under management:** $150M–$300M (Altss estimate)
- **Website:** ventures.sprim.com
- **LinkedIn:** https://www.linkedin.com/company/sprim

## Regulatory record

- **Reports private funds:** No

## About

Sprim Ventures is a venture capital firm that invests in early-stage health solutions. It leverages SPRIM's sourcing, screening, and selection processes. The firm benefits from SPRIM's established relationships with large healthcare companies, global infrastructure of 19 offices, and potential partnerships with over 400 global customers.

## Sectors

- Digital Health
- Healthcare Services
- FemTech
- Biotech
- Food & Nutrition
- Pet Care

## Offices

- Paris, France
- San Francisco, CA, United States

## People

- Michael Guez — Founder & Managing Partner
- Jon Soberg — Managing Partner, US

## Questions

### Who makes investment decisions at Sprim Ventures?

Founder and Managing Partner Michael Guez leads the firm from Singapore alongside Managing Partner Jon Soberg, who runs US operations out of San Francisco. Guez is a second-generation member of the family behind SPRIM, the global health consultancy. Investment decisions draw on the firm's partnership team and its C-LEVEL roster of sector operators.

### How does Sprim Ventures source its deal flow?

Sprim sources through its global healthcare consultancy SPRIM, which maintains relationships with pharmaceutical, nutrition, and consumer-health clients across 19 offices. The consultancy gives the venture arm early visibility into regulatory shifts, reimbursement changes, and clinician adoption patterns before they surface in public markets. The firm's presence in Singapore also surfaces Southeast Asian health-tech startups that sit outside typical Sand Hill Road deal flow.

### Does Sprim provide operational support beyond capital?

Yes. Through its C-LEVEL consultancy, Sprim places full-time operators inside portfolio companies on six-to-eighteen-month engagements. These executives handle regulatory strategy, product-market fit, and go-to-market execution — areas where early-stage health-tech founders often lack in-house expertise. This model reduces the operational risk that kills many pre-revenue health companies.

### Which sectors does Sprim explicitly avoid?

Sprim concentrates exclusively on human and animal health, nutrition, and wellness. It does not invest in generalist software, fintech, enterprise SaaS, or pure biotech plays outside its consumer-facing thesis areas. The firm has publicly stated its intention to lean further into women's health and longevity, signaling a narrower — not broader — sector aperture going forward.

### Where does Sprim Ventures' capital come from?

Founding capital originated with the Guez family, who built SPRIM into a global health consultancy serving multinational pharmaceutical and consumer companies. The firm now raises from a mix of family offices, institutional allocators, and high-net-worth individuals, with family capital remaining a core anchor. The exact AUM composition is not publicly disclosed.

## Related profiles

- [Sprig Equity](https://altss.com/profile/sprig-equity)
- [Sprincz Advisory Group](https://altss.com/profile/sprincz-advisory-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sprim-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology